FDA Licenses New Hepatitis B Vaccine Despite Big Safety Concerns
In February 2018, the Advisory Committee on Immunizations Practices (ACIP) of the Centers for Disease Control and Prevention (CDC) approved the recommendation for a new hepatitis B vaccine, Heplisav-B (HepB-CpG) targeting for adults over the age of 18.1 Heplisav-B is manufactured by Dynavax Technologies Corp. and the new vaccine is given in a two-dose series versus the three […]
Defective DTaP Vaccines in China Due to “Uneven Ratio of Liquid”?
China’s top drug regulator, the China Food and Drug Administration (CFDA), announced on July 31, 2018 that a temporary equipment malfunction was to blame for the production of 400,520 faulty DTaP (diphtheria, tetanus, acellular pertussis) vaccines by Chinese pharmaceutical company Wuhan Institute of Biological Products Co. Ltd. of Wuhan (Hubei province), China.1 According to the China News […]
Mast Cell Disease and Vaccination: Is There Increased Risk?
Do you or does someone you know have severe symptoms of itching, rashes, flushing, stomach or other body pain, frequent diarrhea, nausea, fatigue, brain fog, headache and severe allergies to certain foods, medications or insect stings that may include fainting episodes or anaphylaxis? Although it has been classified as a rare immune system disorder, there […]
Two Infants in Samoa Die After Getting the MMR Vaccine
Samoan government health officials have issued a recall of the MMR (measles, mumps and rubella) vaccine after two infants, a girl and a boy, died on July 6, 2018 just hours after being given the combination vaccine at Safotu Hospital on the island of Savai’i in Samoa. 1 2 3 4 Testing is underway by […]
Two Infants and a Toddler in India Die Shortly After Vaccinations
Three children ranging from ages two months to three and a half years recently died in India following vaccinations. The first child, two-month-old Sharika Sharma, died on June 10, 2018, the morning after she was administered the second round of vaccinations under the Indian government routine vaccination program at the Community Health Center (CHC) in […]
Dengvaxia Vaccine Raises Risk of Severe Dengue Infection
In late-2017, vaccine manufacturer Sanofi Pasteur announced that its dengue vaccine, Dengvaxia, could possibly lead to more severe cases of dengue fever in some people. Studies revealed that giving the vaccine to people who had never contracted the disease leaves them vulnerable to a severe reaction if they subsequently contract the disease. This announcement came after 700,000 children were already given the vaccine in the Philippines. According to Sanofi, those at risk were those who had never been previously infected with the dengue virus.